Universal Biosensors (ASX:UBI) Total Stockholders Equity : A$13.53 Mil (As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Total Stockholders Equity?

Universal Biosensors's Total Stockholders Equity for the quarter that ended in Mar. 2025 was A$13.53 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Universal Biosensors's Book Value per Share for the quarter that ended in Mar. 2025 was A$0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Universal Biosensors's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.26.

Universal Biosensors Total Stockholders Equity Historical Data

The historical data trend for Universal Biosensors's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Total Stockholders Equity Chart

Universal Biosensors Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

37.98

27.61

26.09

19.51

17.37

Universal Biosensors Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															18.66	24.38	20.91	17.37	13.53

Universal Biosensors (ASX:UBI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Universal Biosensors's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(13.528	-	0)	/	298.067
	=	0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Universal Biosensors's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.229	+	2.326)	/	13.528
	=	0.26

Universal Biosensors Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Biosensors Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Corporate Avenue, Rowville, VIC, AUS, 3178

Website

https://www.universalbiosensors.com

Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.

Universal Biosensors Headlines

No Headlines